Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: A meta-analysis of statin trials.
Journal of the American College of Cardiology.
Times cited: 303
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: A meta-analysis.
Times cited: 105
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: A meta-analysis.
JAMA - Journal of the American Medical Association.
Times cited: 430
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: An analysis from the JUPITER trial.
Times cited: 172